Mendel Money Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-273
| Closed | -$263K | – | 134 |
|
|
2024
Q1 | $263K | Buy |
273
+1
| +0.4% | +$962 | 0.12% | 117 |
|
|
2023
Q4 | $239K | Sell |
272
-18
| -6% | -$15.8K | 0.11% | 121 |
|
|
2023
Q3 | $239K | Hold |
290
| – | – | 0.13% | 118 |
|
|
2023
Q2 | $208K | Hold |
290
| – | – | 0.11% | 122 |
|
|
2023
Q1 | $238K | Sell |
290
-10
| -3% | -$8.22K | 0.13% | 119 |
|
|
2022
Q4 | $216K | Sell |
300
-4
| -1% | -$2.89K | 0.12% | 118 |
|
|
2022
Q3 | $209K | Buy |
+304
| New | +$209K | 0.13% | 112 |
|
|
2022
Q2 | – | Sell |
-307
| Closed | -$214K | – | 121 |
|
|
2022
Q1 | $214K | Buy |
+307
| New | +$214K | 0.1% | 120 |
|